Methylmalonic Acidemia Clinical Trial
Official title:
A Non-Interventional Post-Authorization Safety Study (PASS) of Carbaglu® for the Treatment of Hyperammonemia Due to Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA) in Adult and Pediatric Patient Populations
To obtain short-term and long-term clinical safety information, in pediatric and adult patients with PA and MMA treated with Carbaglu®.
This study is being conducted to obtain short-term and long-term clinical safety information from adult and pediatric patients treated for hyperammonemia due to Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA). This is an observational/non-interventional study. Patients will be treated per the prescribing information and routine medical practice. Only available data will be collected as part of the study including developmental outcomes, details of treatment with Carbaglu® and other treatments for hyperammonemia including dietary and protein management, plasma ammonia levels, pregnancy and maternal complications, adverse effects on the developing fetus and neonate, adverse effects on the infant through first year of life. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05842837 -
A Non-Interventional Post-Authorization Study of Carbaglu for the Treatment of Hyperammonemia Due to MMA and PA
|
||
Completed |
NCT01599286 -
Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia
|
Phase 2 | |
Completed |
NCT02426775 -
Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia
|
Phase 3 | |
Terminated |
NCT04581785 -
Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia
|
Phase 1/Phase 2 | |
Recruiting |
NCT05295433 -
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
|
Phase 1/Phase 2 | |
Terminated |
NCT04836494 -
A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia
|
Phase 1 | |
Completed |
NCT03484767 -
"The MaP Study": Mapping the Patient Journey in MMA and PA
|
||
Terminated |
NCT04732429 -
Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia
|
Phase 2 | |
Recruiting |
NCT00078078 -
Clinical and Laboratory Study of Methylmalonic Acidemia
|
||
Active, not recruiting |
NCT05506254 -
Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy
|
||
Recruiting |
NCT04176523 -
Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
|
||
Recruiting |
NCT01289158 -
Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study
|
N/A | |
Withdrawn |
NCT01341379 -
Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate
|
Phase 2 | |
Recruiting |
NCT04899310 -
A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia
|
Phase 1/Phase 2 | |
Terminated |
NCT05438485 -
Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia
|